Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nanoscale

• Publication date

  2017-01-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/c6nr07581aPMID 28009915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery.

  2016cited by this paper
• Glucan microparticles thickened with thermosensitive gels as potential carriers for oral delivery of insulin.

  2016cited by this paper
• Tracking translocation of glucan microparticles targeting M cells: implications for oral drug delivery.

  2016cited by this paper
• Brain targeting by intranasal drug delivery (INDD): a combined effect of trans-neural and para-neuronal pathway

  2016cited by this paper
• Grapefruit-derived Nanovectors Delivering Therapeutic miR17 Through an Intranasal Route Inhibit Brain Tumor Progression.

  2016cited by this paper
• Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.

  2016cited by this paper
• Environment-responsive aza-BODIPY dyes quenching in water as potential probes to visualize the in vivo fate of lipid-based nanocarriers.

  2015cited by this paper
• Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.

  2015cited by this paper
• Nose-to-Brain Delivery: Investigation of the Transport of Nanoparticles with Different Surface Characteristics and Sizes in Excised Porcine Olfactory Epithelium.

  2015cited by this paper
• Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration.

  2015cited by this paper
• Microemulsion-based drug delivery system for transnasal delivery of Carbamazepine: preliminary brain-targeting study

  2014cited by this paper
• Chitosan in nasal delivery systems for therapeutic drugs.

  2014cited by this paper
• Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting

  2014cited by this paper
• Strategies to deliver peptide drugs to the brain.

  2014cited by this paper
• Donepezil nanosuspension intended for nose to brain targeting: In vitro and in vivo safety evaluation.

  2014cited by this paper
• Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles.

  2013cited by this paper
• Liposomes interiorly thickened with thermosensitive nanogels as novel drug delivery systems.

  2013cited by this paper
• Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration.

  2013cited by this paper
• Physicochemical and physiological considerations for efficient nose-to-brain targeting

  2012cited by this paper
• Solid lipid nanoparticles of ondansetron HCl for intranasal delivery: development, optimization and evaluation

  2012cited by this paper
• Absorption, disposition and pharmacokinetics of nanoemulsions.

  2012cited by this paper
• Intranasal delivery of therapeutic proteins for neurological diseases

  2011cited by this paper
• Cell-Penetrating Peptide-Modified Block Copolymer Micelles Promote Direct Brain Delivery via Intranasal Administration

  2011cited by this paper
• Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures.

  2010cited by this paper
• Microemulsion based intranasal delivery system for treatment of insomnia

  2009cited by this paper
• Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium

  2009cited by this paper
• Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting

  2008cited by this paper
• Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption.

  2005cited by this paper
• Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles

  2005cited by this paper
• Intranasal mucoadhesive microemulsions of zolmitriptan: Preliminary studies on brain-targeting

  2005cited by this paper
• Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.

  2004cited by this paper
• Effect of Chitosan on Epithelial Cell Tight Junctions

  2004cited by this paper
• Nasal drug delivery--possibilities, problems and solutions.

  2003cited by this paper
• Studies on the Internalization Mechanism of Cationic Cell-penetrating Peptides*

  2003cited by this paper
• Levels of dopamine in blood and brain following nasal administration to rats.

  2001cited by this paper
• Distribution of antihistamines into the CSF following intranasal delivery.

  1997cited by this paper

• Impact of Textile-Derived Micro- and Nanoplastics on Brain Health: An Emerging Environmental Risk.

  2026cites this paper
• Overcoming translational barriers in nose-to-brain drug delivery for clinical applications.

  2026cites this paper
• Tracking In Vivo Lipolysis of Lipid Nanocarriers Using NIR‐II Polarity‐Sensitive Fluorescent Probes

  2025cites this paper
• Peptide Therapeutics: Current Status and Future Opportunity with Focus on Nose-to-Brain Delivery.

  2025cites this paper
• Advancements in Nanocarrier Systems for Nose-to-Brain Drug Delivery

  2025cites this paper
• Förster Resonance Energy Transfer (FRET) Demonstrates In Vitro Chitosan-Coated Nanocapsules Suitability for Intranasal Brain Delivery

  2025cites this paper
• Exploring intranasal delivery of peptide and protein nanoparticles by a thermoresponsive hydrogel

  2025cites this paper
• In Vitro Evaluation of the Efficient Passage of PLGA-Formulated Trastuzumab for Nose-to-Brain Delivery

  2025cites this paper
• Role of natural plant extracts and hyaluronic acid derivatives in intranasal strategies for brain delivery. A review.

  2025cites this paper
• Self-assembling TLR2 agonists promote mucosal immune responses without pulmonary immunopathologic injuries in mice

  2025cites this paper
• Nose-to-Brain Drug Delivery

  2025cites this paper
• Nasal Nanotherapeutics for Central Nervous System Disorders: Bridging the Translational Gap in Central Nervous System Drug Delivery.

  2025cites this paper
• Surface-engineered chitosan-coated nanostructured lipid carriers for intranasal delivery of Oxcarbazepine and Vitamin E oil in epilepsy management

  2025cites this paper
• Nanoparticles Navigating the Intranasal Route: Innovative Approaches in Neurodegenerative Diseases

  2025cites this paper
• [Development of Drug Delivery Systems Based on New Concepts].

  2025cites this paper
• Intranasal delivery systems for traumatic brain injury: Advancements and perspectives

  2025cites this paper
• Progress in nasal drug delivery research based on biomaterials

  2025cites this paper
• Fluorescence bioimaging of drug nanocarriers based on Förster resonance energy transfer, aggregation-induced emission and aggregation-caused quenching

  2025cites this paper
• Characterization of a custom 3D-printed microfluidic aerosolizer for enhanced nose-to-brain delivery of nanoemulsion.

  2025cites this paper
• Revolutionizing Parkinson’s treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy

  2025cites this paper
• Intranasal delivery of liposome encapsulated flavonoids ameliorates l-DOPA induced dyskinesia in hemiparkinsonian mice.

  2024cites this paper
• Potential of Chitosan for Targeted Mitochondrial Delivery of Therapeutic Agents

  2024cites this paper
• Emissive triphenylamine functionalised 1,8-naphthalimide and naphthalene diimide fluorophores: aggregation, computation and biological studies.

  2024cites this paper
• Non-Invasive Techniques of Nose to Brain Delivery Using Nanoparticulate Carriers: Hopes and Hurdles

  2024cites this paper
• Preparation, physicochemical characterization, ex vivo, and in vivo evaluations of asiatic acid-loaded solid lipid nanoparticles formulated with natural waxes for nose-to-brain delivery.

  2024cites this paper
• Intranasal Carrier-Free Nanomodulator Addresses Both Symptomatology and Etiology of Alzheimer's Disease by Restoring Neuron Plasticity and Reprogramming Lesion Microenvironment.

  2024cites this paper
• Microplastic pollution scenario and its effects on public health and ecosystem: a Bangladesh perspective

  2024cites this paper
• Insight into central nervous system targeted nanostructured lipid carriers via the nose to brain pathway

  2024cites this paper
• Intranasal delivery of imaging agents to the brain

  2024cites this paper
• Liposomal Formulations of Anti-Alzheimer Drugs and siRNA for Nose-to-Brain Delivery: Design, Safety and Efficacy In Vitro

  2024cites this paper
• Design of experiment (DoE) of mucoadhesive valproic acid-loaded nanostructured lipid carriers (NLC) for potential nose-to-brain application.

  2024cites this paper
• Green Solid Lipid Nanoparticles by Fatty Acid Coacervation: An Innovative Nasal Delivery Tool for Drugs Targeting Cerebrovascular and Neurological Diseases

  2024influential citation
• Revolutionizing nanomedicine: Expanding horizons of nanoemulsions in drug delivery and beyond

  2024cites this paper
• Chitosan-coated nanoemulsion for the direct nose-to-brain delivery of sildenafil: Development and in vivo evaluation in a brain oxidative stress and inflammation model

  2024cites this paper
• To see or not to see: In vivo nanocarrier detection methods in the brain and their challenges.

  2024cites this paper
• Bio–Nano Toolbox for Precision Alzheimer's Disease Gene Therapy

  2024cites this paper
• Optimizing Intranasal Amisulpride Loaded Nanostructured Lipid Carriers: Formulation, Development, and Characterization Parameters.

  2024cites this paper
• Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport

  2024cites this paper
• BV2 Membrane‐Coated PEGylated‐Liposomes Delivered hFGF21 to Cortical and Hippocampal Microglia for Alzheimer's Disease Therapy

  2024cites this paper
• Parameter characteristics in intranasal drug delivery: A key to targeting medications to the olfactory airspace.

  2024cites this paper
• Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway.

  2024cites this paper
• Lipid-based nanoparticles via nose-to-brain delivery: a mini review

  2023cites this paper
• Intranasally Administered MSC-Derived Extracellular Vesicles Reverse Cisplatin-Induced Cognitive Impairment

  2023cites this paper
• Role of particle size in translational research of nanomedicines for successful drug delivery: discrepancies and inadequacies.

  2023cites this paper
• Development and pharmacokinetic evaluation of Neusilin® US2-based S-SNEDDS tablets for bosentan: Fasted and fed states bioavailability, IVIS® real-time biodistribution, and ex-vivo imaging.

  2023cites this paper
• Preserving and enhancing mitochondrial function after stroke to protect and repair the neurovascular unit: novel opportunities for nanoparticle-based drug delivery

  2023cites this paper
• Mitochondria-Targeted Delivery Strategy of Dual-Loaded Liposomes for Alzheimer’s Disease Therapy

  2023cites this paper
• Chitosan coated niosomes for nose-to-brain delivery of clonazepam: Formulation, stability and permeability studies.

  2023cites this paper
• A prestin-targeting peptide-guided drug delivery system rearranging concentration gradient in the inner ear: an improved strategy against hearing loss.

  2023cites this paper
• Selection of an aggregation-caused quenching-based fluorescent tracer for imaging studies in nano drug delivery systems.

  2023cites this paper
• Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease.

  2023cites this paper
• Establishment of In Vitro Dissolution Based on Similarity with In Vivo Dissolution: A Case Study on Aripiprazole.

  2023cites this paper
• Nose-to-Brain Targeting via Nanoemulsion: Significance and Evidence

  2023cites this paper
• Development and Comparative In Vitro and In Vivo Study of BNN27 Mucoadhesive Liposomes and Nanoemulsions for Nose-to-Brain Delivery

  2023cites this paper
• Exploring the potential to enhance drug distribution in the brain subregion via intranasal delivery of nanoemulsion in combination with borneol as a guider

  2023cites this paper
• Design of experiment (DoE) as a quality by design (QbD) tool to optimise formulations of lipid nanoparticles for nose-to-brain drug delivery

  2023cites this paper
• Intranasal administration nanosystems for brain-targeted drug delivery

  2023cites this paper
• Nasal Absorption Enhancement of Mometasone Furoate Nanocrystal Dispersions

  2023cites this paper
• Optimization of Bromocriptine-Mesylate-Loaded Polycaprolactone Nanoparticles Coated with Chitosan for Nose-to-Brain Delivery: In Vitro and In Vivo Studies

  2023cites this paper
• Applications of Polymeric Nanoparticle in Nose to Brain Drug Delivery

  2023cites this paper
• Intranasal lipid nanocarriers: Uptake studies with fluorescently labeled formulations.

  2022cites this paper
• Nose-to-brain/spinal cord delivery kinetics of liposomes with different surface properties.

  2022cites this paper
• The spatial-dimensional and temporal-dimensional fate of nanocarrier-loaded dissolving microneedles with different lengths of needles

  2022cites this paper
• Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery

  2022cites this paper
• Microscale and nanoscale chitosan-based particles for biomedical use

  2022cites this paper
• Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review

  2022cites this paper
• Computational Study of Magnetic Particle Motion inside the Nasal Cavity under the Impact of an External Magnetic Field for Biomedical Applications

  2022cites this paper
• for Intranasal Drug Delivery: Preparation and Characterization

  2022cites this paper
• Design and evaluation of chrysin-loaded nanoemulsion against lithium/pilocarpine-induced status epilepticus in rats; emphasis on formulation, neuronal excitotoxicity, oxidative stress, microglia polarization, and AMPK/SIRT-1/PGC-1α pathway

  2022cites this paper
• Modelling the biodistribution of inhaled gold nanoparticles in rats with interspecies extrapolation to humans.

  2022cites this paper
• Dual-targeted magnetic mesoporous silica nanoparticles reduce brain amyloid-β burden via depolymerization and intestinal metabolism

  2022cites this paper
• Neuroendocrine microRNAs linked to energy homeostasis: future therapeutic potential

  2022cites this paper
• Brain targeted delivery of carmustine using chitosan coated nanoparticles via nasal route for glioblastoma treatment.

  2022cites this paper
• Investigation of the “Nose-to-Brain” Pathways in Intranasal HupA Nanoemulsions and Evaluation of Their in vivo Pharmacokinetics and Brain-Targeting Ability

  2022cites this paper
• Application of nano drug loading systems in the treatment of neurological infections: update review.

  2022cites this paper
• Biological and Intracellular Fates of Drug Nanocrystals through Different Delivery Routes: Recent Development Enabled by Bioimaging and PK Modeling.

  2022cites this paper
• Design and development of chitosan-insulin-transfersomes (Transfersulin) as effective intranasal nanovesicles for the treatment of Alzheimer's disease: In vitro, in vivo, and ex vivo evaluations.

  2022cites this paper
• Studies of Mucosal Irritation and Cellular Uptake Mechanisms of Xingnaojing Nanoemulsion

  2022cites this paper
• Neuroprotection by resveratrol: A review on brain delivery strategies for Alzheimer’s and Parkinson’s disease

  2022cites this paper
• Intranasal Nanoemulsions A Potential Strategy for Targeting The Neurodegenerative Disorder: Parkinson's.

  2022cites this paper
• Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review

  2022cites this paper
• Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients

  2022cites this paper
• Microplastics exposure affects neural development of human pluripotent stem cell-derived cortical spheroids.

  2022cites this paper
• New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders: Combining with intranasal delivery

  2022cites this paper
• Drug delivery to the central nervous system

  2021cites this paper
• Comparative evaluation of intranasally delivered quetiapine loaded mucoadhesive microemulsion and polymeric nanoparticles for brain targeting: pharmacokinetic and gamma scintigraphy studies

  2021cites this paper
• Nose-to-brain delivery of disulfiram nanoemulsion in situ gel formulation for glioblastoma targeting therapy.

  2021cites this paper
• Switching luminescence of organogold(I) between aggregation-induced phosphorescence enhancement and aggregation-caused quenching by balancing auxiliary ligands around AuI center.

  2021cites this paper
• Intranasal artesunate-loaded nanostructured lipid carriers: A convenient alternative to parenteral formulations for the treatment of severe and cerebral malaria.

  2021cites this paper
• Microemulsion as a promising carrier for nose to brain delivery: journey since last decade

  2021cites this paper
• Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies

  2021cites this paper
• Extracellular vesicles for the treatment of central nervous system diseases.

  2021cites this paper
• Nose to brain drug delivery of nanoformulations in the treatment of migraine

  2021cites this paper
• Design, Optimization and Pharmacokinetic Evaluation of Piribedil Loaded Solid Lipid Nanoparticles Dispersed in Nasal In Situ Gelling System for Effective Management of Parkinson's Disease.

  2021cites this paper
• Recent progress in nanocarriers for direct nose to brain drug delivery

  2021cites this paper
• Anti-aging properties of phytoconstituents and phyto-nanoemulsions and their application in managing aging-related diseases.

  2021cites this paper
• Intranasal gene therapy for the treatment of neurological disorders

  2021cites this paper
• Surface modification of nanocarriers as a strategy to enhance the direct nose-to-brain drug delivery

  2021cites this paper
• Particulate carriers for nose-to-brain delivery

  2021cites this paper
• Toxicity aspects: Crucial obstacles to clinical translation of nanomedicines

  2021cites this paper